SNWV Sanuwave Health Inc
Price (delayed)
$33.75
Market cap
$288.51M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$7.03
Enterprise value
$303.77M
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally.
Highlights
The equity has surged by 79% since the previous quarter and by 71% year-on-year
The gross profit has soared by 71% year-on-year and by 15% since the previous quarter
Sanuwave Health's EPS has shrunk by 176% QoQ but it has increased by 42% YoY
The net income has declined by 22% year-on-year
Key stats
What are the main financial stats of SNWV
Market
Valuations
Earnings
Shares outstanding
8.55M
Market cap
$288.51M
Enterprise value
$303.77M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
4.62
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
9.31
Revenue
$32.63M
Gross profit
$24.55M
Operating income
$5.42M
Net income
-$31.37M
EBIT
-$17.71M
EBITDA
-$16.56M
Free cash flow
$1.97M
Per share
Balance sheet
Liquidity
EPS
-$7.03
EPS diluted
-$7.03
Free cash flow per share
$0.44
Book value per share
-$1.49
Revenue per share
$7.31
TBVPS
$4.29
Total assets
$30.12M
Total liabilities
$42.84M
Debt
$25.5M
Equity
-$12.72M
Working capital
-$23.95M
Debt to equity
-2
Current ratio
0.43
Quick ratio
0.32
Net debt/EBITDA
-0.92
Margins
Efficiency
Dividend
EBITDA margin
-50.8%
Gross margin
75.2%
Net margin
-96.1%
Operating margin
16.6%
Return on assets
-130.3%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
-54.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SNWV stock price
How has the Sanuwave Health stock price performed over time
Intraday
-10.5%
1 week
-10.05%
1 month
N/A
1 year
N/A
YTD
N/A
QTD
-4.58%
Financial performance
How have Sanuwave Health's revenue and profit performed over time
Revenue
$32.63M
Gross profit
$24.55M
Operating income
$5.42M
Net income
-$31.37M
Gross margin
75.2%
Net margin
-96.1%
The gross profit has soared by 71% year-on-year and by 15% since the previous quarter
SNWV's revenue has soared by 60% YoY and by 11% QoQ
The operating income has grown by 38% from the previous quarter
Sanuwave Health's net margin has increased by 24% YoY
Growth
What is Sanuwave Health's growth rate over time
Valuation
What is Sanuwave Health stock price valuation
P/E
N/A
P/B
N/A
P/S
4.62
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
9.31
Sanuwave Health's EPS has shrunk by 176% QoQ but it has increased by 42% YoY
The equity has surged by 79% since the previous quarter and by 71% year-on-year
SNWV's revenue has soared by 60% YoY and by 11% QoQ
Efficiency
How efficient is Sanuwave Health business performance
Sanuwave Health's return on sales has decreased by 9% YoY
Dividends
What is SNWV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SNWV.
Financial health
How did Sanuwave Health financials performed over time
Sanuwave Health's total assets is 30% lower than its total liabilities
The current ratio has soared by 187% YoY
Sanuwave Health's total liabilities has decreased by 48% from the previous quarter and by 35% YoY
The debt to equity has shrunk by 170% YoY
The equity has surged by 79% since the previous quarter and by 71% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.